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1. Introduction
  Hypertension, which is characterized by multiple 
alterations in the structure and function of the cell 
membrane, is often associated with important metabolic 
abnormalities including those concerning lipid metabolism. 
Lipids, as an integral part of the cell membrane, play 
a decisive role in the modulation of the membrane 
properties mentioned. Specific lipid-lipid and lipid-
protein interactions result in a highly dynamic but precisely 
controlled architecture of membrane components. Major 
regulators of membrane architecture are membrane 
potential, intracellular Ca2+ and pH, lipid composition, 
cell-to-cell contact, and membrane coupling with the 
cytoskeleton or extracellular matrix. Intermolecular 
associations in the membrane and at the membrane-
cytoskeleton interface are further selectively controlled by 
specific phosphorylation and dephosphorylation cascades 
involving both proteins and lipids. This is regulated by the 
extracellular matrix as well as by the binding of growth 
factors and hormones to their specific receptors[1, 2].
  Multiple metabolic abnormalities often accompany 
essential hypertension. Decreased high-density lipoproteins 
(HDL) together with increased plasma levels of low-density 
(LDL) and very low-density lipoproteins (VLDL), as well as 
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hypertriglyceridemia, hypercholesterolemia, and insulin 
resistance, were found in many hypertensive patients[3,4]. 
There is increasing evidence for a genetic basis for the 
association of hypertension with insulin resistance and 
dyslipidemia. In spontaneously hypertensive rats (SHR) and 
DOCA salt rats, abnormal lipid metabolism were detected[5]. 
Changes in both circulating and membrane lipids were 
observed in SHR and DOCA-salt prior to hypertension 
development[6]. The alterations of membrane cholesterol 
or phospholipids content, phospholipid distribution, 
molecular species pattern of particular phospholipid 
classes, and degree of fatty acid saturation were reported in 
both human[7,8] and experimental hypertension[9,10]. These 
changes in membrane lipid composition may modulate 
membrane function in a long term manner, contributing to 
abnormal chronic BP regulation.
  In our earlier study we have investigated ethanolic extract 
of Melothria maderaspatana (M. maderaspatana) and shown 
to possess antihypertensive activity on DOCA-salt induced 
hypertensive rats at the optimum dose of 200 mg/kg BW[11]. 
Previously, there is no reported that the antihyperlipidemic 
effect of CEEM on DOC-salt induced hypertensive rats. 
Therefore, in the present study the main aim was to 
investigate the effects of CEEM on ameliorate the lipid 
metabolism on DOCA-salt induced hypertensive rats.
2. Materials and methods
2.1. Preparation of leaf extract 
  Melothria maderaspatana leaf powder was purchased from 
the local herbal market (Vinayaga herbals), Chidambaram, 
Cuddalore district,  Tamil Nadu, India. Leaves of
M. maderaspatana were collected from the same local herbal 
market and the plant was botanically authenticated. A 
voucher specimen (AU-6054) of the plant has been deposited 
at the Herbarium of the Department of Botany, Annamalai 
University, Annamalainagar, Tamil Nadu. The leaf powder 
was sieved and kept in a freezer until use. 100 g of dry fine 
powder was suspended in 300 mL of ethanol for 72 h. The 
extract was filtered using a muslin cloth and concentrated at 
(40 ± 5) 曟.  The extract was kept in deep freezer until use.
2.2. Animals
  Male albino Wistar rats (weighing 200-230 g) were 
purchased from the Central Animal House, Department of 
Experimental Medicine, Rajah Muthiah Medical College 
and Hospital, Annamalai University, and maintained in an 
airconditioned room (25 ± 1) 曟 with a 12 h light/12 h dark 
cycle. Feed and water were provided ad libitum. Animal 
handling and experimental procedures were approved by 
the Institutional Animal Ethics Committee, Annamalai 
University (Registration Number: 66/1999/CPCSEA, Proposal 
No. 459) and animals were cared in accordance with the 
Committee for the purpose of control and supervision on 
experimental animals” (CPCSEA, 2004).
2.3. Chemicals 
  DOCA-salt was obtained from Sigma-Aldrich Company 
(St. Louis, Missouri, USA). All other chemicals used were 
of analytical grade obtained from E. Merck or HIMEDIA, 
Mumbai, India.
2.4. Method of uninephrectomy
  Animals were anesthetized by an intraperitoneal injection 
of ketamine (75 mg/kg body weight [BW]). A small patch 
of skin above the left kidney was shaved and cleaned and 
iodine-based antiseptic was applied. A 1 cm incision was 
made at midscapular region. The kidney was freed from 
the surrounding tissues and gently pulled out. The adrenal 
gland, which is attached loosely to the anterior pole of 
the kidney by connective tissue and fat, was gently freed 
by tearing the attachments, and was put back into the 
abdominal cavity. The renal artery and ureter were tied 
by silk thread, severed and then the kidney was removed. 
The muscle and skin layers were closed separately using 
a chromic sterile absorbable suture. After 1 week recovery 
period the animals were used for further experiments.
2.5. Experimental induction of hypertension 
  Animals were given twice-weekly subcutaneous injections 
of DOCA (25 mg/kg BW) in dimethyl formamide (vehicle) 
solution and salt was administered by substitution of 1% 
NaCl solution for drinking water ad libitum throughout the 
experimental period.
2.6. Experimental design
  The animals were randomly divided into five groups of six 
animals each. CEEM or nifedipine was suspended in 0.5% 
dimethyl sulphoxide (DMSO) and administered by intubation 
(p.o.) once in a day, between 9 a.m. and 10 a.m., for 6 weeks.
Group 1 Sham-operated control (0.5% DMSO only)
Group 2 Sham-operated control + CEEM (200 mg/kg BW of 
0.5% DMSO)
Group 3 DOCA-salt + 1% NaCl 
Group 4 DOCA-salt + 1% NaCl + CEEM (200 mg/kg BW of 
0.5% DMSO)
Group 5 DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW of 
0.5% DMSO)
  After 6 weeks, the animals were anaesthetized, using 
ketamine (intramuscular injection), and killed between 8 
a.m. and 9 a.m. by cervical dislocation. Blood and tissues 
(liver, kidney and heart) were collected for the measurement 
of various biochemical parameters.
2.7. Biochemical analysis
  Total lipids were extracted from the liver, kidney and 
heart tissues according to the method of Folch et al[12]. 
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Total cholesterol was estimated by the method of Allain et 
al[13]. HDL-C was estimated by the method of Izzo et al[14]. 
Atherogenic index was calculated by the method of Malspina 
et al[15] VLDL-C and LDL-C were calculated by the method 
of Friedewald et al[16]. Triglycerides were estimated by the 
method of McGowan et al[17]. Free fatty acid content was 
estimated by the method of Falholt et al[18]. Phospholipid 
was estimated by the method of Silversmit and Davis[19].
2.8. Statistical analysis
  Statistical evaluation was performed using a one-way 
analysis of variance (ANOVA), followed by Duncan’s multiple 
range test (DMRT) using the statistical package of social 
science (SPSS) version 10.0. The significance level was set at 
P < 0.05.
3. Results
  Tables 1, 2, 3 and 4 show the effect of CEEM on TC, TG, 
FFA and PL in the plasma and tissues of sham-operated 
and DOCA-salt hypertensive rats. The levels of plasma 
and tissue TC, TG, FFA and PL increased in DOCA-salt 
hypertensive rats and administration of CEEM showed a 
significant reduction in these parameters. 
  Table 5 shows the effect of CEEM on HDL-C, VLDL-C 
and LDL-C in the plasma of sham-operated and DOCA-
salt hypertensive rats. The levels of LDL-C and VLDL-C 
significantly increased while HDL-C decreased in 
hypertensive rats and CEEM administration exhibited 
significant reduction in LDL-C and VLDL-C and elevation 
in HDL-C. 
  Figure 1 shows the histological changes in the liver of 
sham-operated and DOCA-salt hypertensive rats. DOCA-
salt rats showed fatty changes in hepatocytes besides 
hypertrophy and globular hyalinization, oedema and 
hydrophic changes. Treatment with CEEM and nifedipine 
reduced the fatty changes of hepatocytes and hypertrophy.
  Figure 2 shows the histological changes in the kidney of 
sham-operated and DOCA-salt hypertensive rats. DOCA-
salt rats showed atrophy of tubular cells with dilated lumen 
of distal convoluted tubules and congestion of glomerulus. 
Treatment with CEEM and nifedipine reduced the congestion 
of glomerulus and focal tubular necrosis. 
  Figure 3 shows the histological changes in the heart 
Sham-operated control  rats 
showing normal hepatocytes and 
central vein.
Sham-operated control  rats 
with CEEM showing normal 
hepatocytes and central vein.
D O C A - s a l t  h y p e r t e n s i v e 
rats  showing fat ty  changes 
of hepatocytes, hypertrophy, 
globular hyalinization, oedema 
and hydrophic changes.
DOCA-salt rats with CEEM 
showing reduced fatty changes 
and hypertrophy.
DOCA-salt rats treated with 
nifedipine showing reduced 
hydrophic changes and globular 
hyalinization.
Figure 1. Histopathological changes of liver (H&E, 100×).
Sham-operated control  rats 
showing normal histology of 
kidney.
Sham-operated control rats with 
CEEM showing normal histology 
of kidney.
DOCA-salt hypertensive rats 
showing atrophy of tubular cells 
with dilated lumen of distal 
convoluted tubules and congestion 
of glomerulus.
DOCA-salt rats treated with 
C E E M  s h o w i n g  r e d u c e d 
congestion of glomerulus and focal 
tubular necrosis.
DOCA-salt  rats treated with 
ni fedipine  showing minimal 
congestion of glomerulus and focal 
tubular necrosis.
Figure 2. Histopathological changes of kidney (H&E, 100×).
Sham-operated control  rats 
showing normal histology of 
cardiac tissue
Sham-operated control rats with 
CEEM   showing normal cardiac 
myocytes.
DOCA-salt hypertensive rats 
showing distortion of cardiac 
myofibri l  arrangement and 
t h i c k e n e d  a r t e r i o l e  w i t h 
hypertrophy.
DOCA-salt rats treated with 
C E E M  s h o w i n g  r e d u c e d 
distortion of cardiac myofibril 
arrangement and hypertrophy.
DOCA-salt rats treated with 
nifedipine showing minimal 
distortion of cardiac myofibril 
arrangement and hypertrophy.
Figure 3. Histopathological changes of heart (H&E, 100×).
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of sham-operated and DOCA-salt hypertensive rats. 
Heart showed distortion of cardiac myofibril arrangement 
and thickened arterial with hypertrophy in DOCA-salt 
hypertensive rats. Administration of CEEM and nifedipine 
reduced distortion of cardiac myofibril arrangement and 
hypertrophy. 
Table 1
Effect of CEEM on total cholesterol, triglycerides, free fatty acids and phospholipids of plasma in sham-operated and uninephrectomized DOCA-
salt hypertensive rats.
Name of the groups TC (mg/dL)         TG (mg/dL) FFA (mg/dL) PL (mg/dL)
Sham-operated control   82.16 ± 5.74a   57.52 ± 3.06a   55.84 ± 4.06a  80.53 ± 6.43a
Sham-operated control + CEEM  (200 mg/kg BW)   79.35 ± 3.36a   55.27 ± 2.38a   53.46 ± 3.81a  78.08 ± 5.68a
DOCA-salt + 1% NaCl 166.73 ± 8.82b 160.39 ± 8.58b  123.58 ± 8.64b   148.91 ± 10.06b
DOCA-salt + 1% NaCl + CEEM  (200 mg/kg BW)   84.47 ± 5.24a   61.29 ± 5.57a   59.57 ± 4.25a   84.27 ± 6.73a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 132.64 ± 6.18c 118.36 ± 6.75c   88.45 ± 5.67c 106.68 ± 7.49c
Values are means ± SD for six rats in each group. Values not sharing a common superscript differ significantly at P < 0.05 (DMRT).
Table 2
Effect of CEEM on total cholesterol, triglycerides, free fatty acids and phospholipids in the liver of sham-operated and uninephrectomized DOCA-
salt hypertensive rats.
Name of the groups
(mg/g wet tissue)
TC TG FFA PL
Sham-operated control 4.37 ± 0.36a 3.63 ± 0.24a   8.48 ± 0.54a 24.57 ± 1.64a
Sham-operated control + CEEM  (200 mg/kg BW) 3.97 ± 0.28a 3.61 ± 0.31a   7.89 ± 0.42a 23.77 ± 1.85a
DOCA-salt + 1% NaCl 6.46 ± 0.46b 7.37 ± 0.54b 15.39 ± 0.97b 45.85 ± 3.03b
DOCA-salt + 1% NaCl + CEEM  (200 mg/kg BW) 4.59 ± 0.23a 3.87 ± 0.37a   8.74 ± 0.67a 25.38 ± 1.84a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 5.86 ± 0.35c 5.47 ± 0.30c 10.48 ± 0.84c 36.26 ± 2.07c
Values are means ± SD for six rats in each group. Values not sharing a common superscript differ significantly at P < 0.05 (DMRT).
Table 3
Effect of CEEM on total cholesterol, triglycerides, free fatty acids and phospholipids in the kidney of sham-operated and uninephrectomized 
DOCA-salt hypertensive rats.
Name of the groups
( mg/g wet tissue )
TC TG FFA PL
Sham-perated control   4.80 ± 0.32a,c 3.52 ± 0.30a 4.63 ± 0.34a 16.57 ± 1.02a
Sham-operated control + CEEM  (200 mg/kg BW) 4.45 ± 0.36a 3.43 ± 0.29a 4.18 ± 0.39a 15.82 ± 1.08a
DOCA-salt + 1% NaCl 7.83 ± 0.57b 6.87 ± 0.54b 9.86 ± 0.56b 30.46 ± 2.45b
DOCA-salt + 1% NaCl + CEEM  (200 mg/kg BW) 4.97 ± 0.38a 3.87 ± 0.33a 4.86 ± 0.36a 17.57 ± 1.54a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 6.19 ± 0.52c 5.13 ± 0.29c 7.43 ± 0.52c 23.58 ± 1.64c
Values are means ± SD for six rats in each group. Values not sharing a common superscript differ significantly at P < 0.05 (DMRT).
Table 4
Effect of CEEM on total cholesterol, triglycerides, free fatty acids and phospholipids in the heart of sham-operated and uninephrectomized 
DOCA-salt hypertensive rats.
Name of the groups
(mg/g wet tissue)
TC TG FFA PL
Sham-operated control 2.57 ± 0.20a 4.64 ± 0.35a   5.47 ± 0.38a 12.07 ± 1.10a
Sham-operated control + CEEM  (200 mg/kg BW) 2.44 ± 0.18a 4.04 ± 0.37a   5.03 ± 0.41a 11.58 ± 0.96a
DOCA-salt + 1% NaCl 4.73 ± 0.32b 6.15 ± 0.59b 10.42 ± 1.07b 22.17 ± 2.12b
DOCA-salt + 1% NaCl + CEEM  (200 mg/kg BW) 2.74 ± 0.21a 4.82 ± 0.28a   5.83 ± 0.54a 13.03 ± 1.17a
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 3.75 ± 0.27c 5.37 ± 0.39c   8.54 ± 0.68c 18.66 ± 1.51c
Values are means ± SD for six rats in each group. Values not sharing a common superscript differ significantly at P < 0.05 (DMRT).
Table  5
Effect of CEEM on HDL-C, VLDL-C and LDL-C in the plasma of sham-operated and uninephrectomized DOCA-salt hypertensive rats.
Name of the groups HDL-C (mg/dL) VLDL-C (mg/dL) LDL-C (mg/dL)
Sham-operated control 46.88 ± 3.06a 11.50  ± 0.67a   23.78 ± 2.28a
Sham-operated control + CEEM  (200 mg/kg BW) 47.64 ± 3.40a 11.05 ± 0.52a   20.66 ± 0.57a
DOCA-salt + 1% NaCl 27.57 ± 2.03b 32.08 ± 1.89b 107.08 ± 5.61b
DOCA-salt + 1% NaCl + CEEM  (200 mg/kg BW) 43.64 ± 3.16a 12.26 ± 1.23a     29.37 ± 1.86a,c
DOCA-salt + 1% NaCl + nifedipine (20 mg/kg BW) 36.07 ± 3.03c 23.67 ± 1.49c    73.70 ± 3.64d
Values are means ± SD for six rats in each group. Values not sharing a common superscript differ significantly at P < 0.05 (DMRT).
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4. Discussion
  Abnormality in lipids and lipoprotein metabolism play 
a central role in the pathogenesis of hypertension. The 
presence of high BP and hyperlipedimia is so common 
in patients with hypertension and animal models of 
hypertension that many have argued that the high BP itself 
may play a role in altering lipid metabolism, resulting in 
abnormalities. Our result showed a decrease in the levels 
of TC, TG, LDL-C, VLDL-C, PL and increase in the level 
of HDL-C in hypertensive rats after treatment with CEEM. 
High levels of total cholesterol and LDL cholesterol are 
major risk factors for cardiovascular diseases, whereas 
increased HDL-cholesterol is associated with a decrease 
in cardiovascular disease risk. It is well known that HDL-
cholesterol plays an important role in the transport of 
cholesterol from the periphery to the liver by the “reverse 
cholesterol transport” pathway. Several studies show that an 
increase in HDL cholesterol is associated with a decrease 
in coronary risk[20,21] and most of the drugs that decrease 
total cholesterol also decrease HDL cholesterol[22]. But in 
the present study the extract decreased the total cholesterol 
and LDL cholesterol and enhanced the HDL cholesterol signi 
cantly.
 This is  an important advantage in treatment of 
hypercholesterolemia especially among Indians where low 
HDL cholesterol is the prevalent lipoprotein abnormality[23]. 
High levels of TC and more importantly, LDL cholesterol 
are major coronary risk factors[24,25]. LDL carries cholesterol 
from the liver to the peripheral cells and smooth muscle 
cells of the arteries, a rise in LDL may cause deposition 
of cholesterol in the arteries and aorta and hence is bad 
for health and a direct risk factor for coronary heart 
disease[26,27]. Administration of CEEM lowered both total 
and LDL cholesterol in experimental rats, which could 
be reducing the incidence of coronary events[28]. The 
decrease of serum TG level is an important finding of this 
experiment. Recent studies also show that triglycerides 
are independently related to coronary heart disease[29] and 
most of the antihypercholesterolemic drugs do not decrease 
triglycerides levels, but CEEM lowered it significantly and 
this effect might be related to increase the endothelium 
bound lipoprotein lipase which hydrolyses the triglycerides 
into fatty acids.
  Phospholipids are vital components of biomembrane and 
play an important role in the transport of triacylglycerol. FFA 
and TC also promote the synthesis of phospholipids. These 
phospholipids and FFA are important for the maintenance of 
cellular integrity, microviscosity and survival[30]. Increased 
levels of plasma phospholipids and FFA were observed in 
hypertensive rats, which might be due to membrane damage 
caused by increased lipid peroxidation. Increased lipid 
peroxidation thought to be consequence of oxidative stress 
that occurs when the dynamic balance between pro-oxidant 
and antioxidant mechanism is impaired[31]. M. maderaspata 
is also being recognised as a potent antioxidant. Increased 
antioxidant levels may decrease lipid peroxidation, thereby 
preventing membrane damage that leads to decreased 
plasma and tissue phospholipids and FFA levels.
  In conclusion, our findings the treatment with CEEM 
has played a major role in lipid metabolism that may be 
due to its antilipidperoxidive effect and the present study 
strongly supports the efficacy of CEEM in controlling lipid 
parameters in serum and liver, kidney and heart of DOCA-
salt hypertensive rats. The biochemical findings were 
supported by histopathological study.  
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